Quantified
MARCH 2, 2023
Sales enablement is not just a buzzword. Companies of all sizes and industries see results when they have concerted programs and efforts supporting growth and training. After two years of these approaches, organizations see a 48% higher customer engagement rate. Most companies are shifting toward including dedicated sales enablement roles or programs in their organization, but many have yet to make the shift.
Fierce Pharma
MARCH 1, 2023
After wild pandemic ride, is Novavax destined to be the little engine that couldn’t?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
MARCH 3, 2023
As regulatory processes and reimbursements are refined, there needs to be a continued focus on how to maximize the benefits for patients and ensure DTx can play a role in improving outcomes. The key to this is integration into the clinical workflow.
Medico Reach
MARCH 2, 2023
The healthcare sector is one of the fastest-growing industries. It is now adapting to new changes and implementing new technologies like artificial intelligence to enhance the patient experience. A compound annual growth rate (CAGR) of 12.25% is a testament to the healthcare segment’s exponential and steady rise. So, as a business in this domain, you must leverage hi-tech solutions to capitalize on the budding market.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Medgadget
FEBRUARY 27, 2023
Researchers at Northwestern University have developed a wearable that can detect when someone is talking or singing, and tallies this information up to provide a warning when the wearer might be at risk of vocal fatigue. Overusing your voice in a short space of time can lead to vocal fatigue and even injury. This technology is useful for patients with vocal disorders, but also for people who rely on their voices a lot, such as singers, politicians, and teachers.
Fierce Pharma
MARCH 1, 2023
Pfizer, Viatris and more must face 'overarching conspiracy' claims in generic price-fixing suit aliu Wed, 03/01/2023 - 10:03
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
Healthcare Success
FEBRUARY 27, 2023
ChatGPT is an artificial intelligence chatbot that can have human-like conversations, translate, and provide users with information. It can also write good content. Like, really good. And now that Google has openly stated, “Appropriate use of AI or automation is not against our guidelines,” it begs the question: Should we use it to produce healthcare content?
Pharmaceutical Technology
MARCH 2, 2023
The US Food and Drug Administration (FDA) has approved Reata Pharmaceuticals ’ oral, once-daily medication SKYCLARYS (omaveloxolone) to treat Friedreich’s ataxia patients. SKYCLARYS is indicated to treat the ultra-rare, inherited neurodegenerative disorder in 16 years and above-aged adults and adolescents in the US. SKYCLARYS is the first approved treatment in Friedrich’s Ataxia and marks a milestone for drug development in this complex disease.
Fierce Pharma
FEBRUARY 28, 2023
FDA turns down Cytokinetics’ once-promising heart failure drug omecamtiv kdunleavy Tue, 02/28/2023 - 18:55
MedCity News
MARCH 3, 2023
In the post-Roe environment of fear and uncertainty, femtech companies should actively review their data collection practices to ensure they are only collecting the minimum amount of data necessary for the app to function. Recent studies have shown that accurate women’s health predictions can be made by some companies that collect far less data than their competitors.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Nixon Gwilt Law
FEBRUARY 27, 2023
Late Friday (February 24, 2023), the US Drug Enforcement Agency (DEA) released a proposed rule to make permanent some of the flexibilities allowed during the Public Health Emergency (PHE) for telemedicine companies whose providers prescribe controlled substances. Keep reading this timely post to find out: What these proposed changes are; How they will impact your telemedicine business; and Where (and how) stakeholders can weigh in on the DEA’s proposal in the 30-day comment period.
European Pharmaceutical Review
MARCH 1, 2023
Large RNA is rapidly emerging as a new class of therapeutics. Nowhere is this more publicly evident than in the development, regulatory approval, and efficacious use of mRNA‑based vaccines for COVID-19. Beyond the high-profile COVID-19 vaccines, mRNA therapeutics are crucial in applications such as protein replacement therapies and regenerative medicine.
Fierce Pharma
MARCH 1, 2023
Eli Lilly slashes insulin prices by 70%, caps out-of-pocket costs in major access overhaul fkansteiner Wed, 03/01/2023 - 08:40
MedCity News
FEBRUARY 26, 2023
Wearable patient devices can provide healthcare organizations with more varied data, expand options for clinical trials, and make patients more active participants in their own care.
Advertiser: ZoomInfo
Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr
Clarivate
MARCH 1, 2023
International research collaboration is critical to scientific discovery. Just as the research landscape grows in complexity, the landscape of collaboration continuously changes, making it more challenging to track progress. At the University of South Florida (USF), the fastest rising university in the U.S. News & World Report’s U.S. rankings, maintaining the pace of global engagement, high-impact research and innovation is supported with a metrics dashboard that informs strategic planning a
Legacy MEDSearch
FEBRUARY 28, 2023
ReCor Medical, Inc. (“ReCor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) today announced that primary endpoint results from the RADIANCE II pivotal trial were published in the Journal of the American Medical Association (JAMA). Study results showed that the Paradise Ultrasound Renal Denervation (uRDN) System successfully reduced blood pressure compared to sham.
Fierce Pharma
FEBRUARY 28, 2023
Merck ends last Keytruda trial in aggressive prostate cancer campaign, takes separate hit in lung cancer aliu Tue, 02/28/2023 - 09:40
MedCity News
MARCH 3, 2023
James Comer (R-Ky), House Committee on Oversight and Accountability chairman, sent letters to the Office of Personnel Management, Centers for Medicare and Medicaid Services and the Defense Health Agency asking for documents that show how PBMs’ practices are affecting federal government healthcare programs. In addition, he sent letters to CVS Caremark, Express Scripts and OptumRx, asking them to provide information on their tactics.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Celeritas
MARCH 3, 2023
Data Analytics is the next phase in the evolutionary data cycle. Today, decades worth of data may be quickly processed to provide insights into the veterinary industry. From identifying the roots of a problem to providing data-rich remedies, data analytics can accomplish much. Animal health is a sector that utilizes the most complex processes and is intensely data-rich.
Clear Pivot
MARCH 3, 2023
We've got some great news to share! After rigorous training, tests, and practical exams, we are excited to announce that ClearPivot has earned the HubSpot Onboarding Accreditation. HubSpot has validated our skills for helping large companies move their operations onto HubSpot.
Fierce Pharma
MARCH 3, 2023
Sanders urges Sanofi, Novo Nordisk to be like Eli Lilly in reducing insulin prices kdunleavy Fri, 03/03/2023 - 10:38
MedCity News
MARCH 2, 2023
Just a quarter of healthcare practices offer remote patient monitoring, and the majority of them aren’t too eager to adopt the technology any time soon, according to a new report. A few factors are influencing this reluctance, including data security concerns, unclear reimbursement policies and training requirements.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Pharmaceutical Technology
MARCH 1, 2023
The US Food and Drug Administration (FDA) has granted approval for Regeneron Pharmaceuticals and Sanofi ’s Kevzara (sarilumab) to treat polymyalgia rheumatica (PMR) in adult patients. Kevzara has been approved as the first and only biologic indicated for PMR adult patients who did not respond to corticosteroids or who cannot tolerate corticosteroid taper.
pharmaphorum
FEBRUARY 27, 2023
Engaging digitally native healthcare professionals requires companies to challenge existing business ethos and commit to the customer experience in an increasingly digital world.
Fierce Pharma
MARCH 1, 2023
Reata scores first FDA approval in its 21-year history, pushing rare disease drug over finish line kdunleavy Wed, 03/01/2023 - 10:31
MedCity News
FEBRUARY 28, 2023
The divide between doctors dedicated to pure research, usually in an academic setting, and those working in community practices, is one of the factors driving well-known disparities in research.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Pharmaceutical Technology
MARCH 2, 2023
Merck has reported an increase in group net sales by 12.9% to €22.23bn in fiscal 2022 against €19.68bn in 2021. The growth in sales was driven by all regions and business sectors, particularly Life Science. Organically, the company generated an increase of 6.4% in group sales in fiscal 2022. Favourable foreign exchange effects of 6.1% resulted primarily from the development of the US dollar and the Chinese renminbi.
PharmaTech
MARCH 2, 2023
This article discusses the evaluation of paired content uniformity and weight variation data sets using F and T tests to ensure that batches meet compendial requirements.
Fierce Pharma
MARCH 1, 2023
Regeneron, Sanofi's Kevzara becomes first biologic approved for polymyalgia rheumatica zbecker Wed, 03/01/2023 - 10:46
MedCity News
MARCH 3, 2023
Cargo Therapeutics is developing CAR T-cell therapies that overcome ways cancers evade currently available treatments. True to its name, the startup’s approach involves putting more cargo and more complex cargo onto engineered T cells.
Advertiser: ZoomInfo
In times of economic uncertainty, account-based strategies are essential. According to several business analysts and practitioners, ABM is a necessity for creating more predictable revenue. Research shows that nearly three-quarters of marketers (74%) already have the resources needed to build successful ABM programs.
Expert insights. Personalized for you.
52 
Let's personalize your content